Close Menu

NEW YORK (GenomeWeb) – A genomic study of non-invasive bladder cancer has identified genomic subtypes of the disease, along with pathways that are more frequently altered relative to muscle-invasive forms of the disease.

"Our improved ability to identify these specific molecular features of individual tumors should allow a more personalized approach to therapy and disease management in the future," senior author Margaret Knowles, a molecular oncology researcher at Leeds Institute of Cancer and Pathology, said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.